The Oklahoman

Why would anyone want a less effective vaccine?

- Adam Cohen & Dr. Stephen Prescott Adam's Journal Prescott, a physician and medical researcher, is president of the Oklahoma Medical Research Foundation. Cohen is a marathoner and OMRF's senior vice president and general counsel. Submit your health questio

Here's a question from

a reader: The Johnson & Johnson COVID-19 vaccine is reported to have an 85% protection rate against severe illness, with even lower efficacy in cases with moderate to lesser symptoms. That's compared with a 94-95% protection rate across the board offered by the Pfizer and Moderna vaccines. Why would anyone want the less effective vaccine from J&J? — Lea Eldridge, Oklahoma City Dr. Prescott Prescribes

The figures you cite are correct. And when it comes to preventing moderate disease, the J&J vaccine lagged even further behind, providing only 72% protection.

As Dr. Anthony Fauci put it, “If you woke up and you say, `Well, go to the door on the left and you get 94 or 95%, go to the door on the right and you get 72%,' which door do you want to go to?”

However, as Fauci then acknowledg­ed, the most important measure is not the ability to stop coughs and body aches but, rather, severe disease, which can lead to hospitaliz­ation and even death. And when it comes to that measure, J&J's 85% figure may actually turn out to be as good — or better — than Pfizer's apparently higher rates of prevention.

Pfizer and Moderna tested their vaccines before more contagious, potentiall­y deadlier variants of the virus began circulatin­g. By the time J&J conducted trials, several of these variants had emerged. The vaccine showed 85% efficacy against severe disease in all countries, including South Africa, where a rapidly spreading variant has shown the ability to escape some vaccines.

So, comparing numbers from the earlier trials to J&J's more recent one is an oranges-apples exercise. Or, more accurately, it's like equating a mile run on a track (Pfizer, Moderna) to one run up a hill (J&J).

In addition, the J&J vaccine offers full protection in a single dose, while Pfizer and Moderna's require a second booster before reaching full strength. That's a powerful advantage, especially in an environmen­t where, for a variety of reasons, many may have difficulty obtaining a second shot.

Given the current supply of vaccines, at least for the foreseeabl­e future, people will not have the luxury of picking and choosing. That means if you have the chance to get a shot, take it immediatel­y, regardless of who made it. The weeks or months you might have to wait — unprotecte­d — for a dose of a “better” vaccine could be the window in which you get infected.

 ?? SENTINEL VIA USA TODAY NETWORK] [MIKE DE SISTI / MILWAUKEE JOURNAL ?? A COVID-19 vaccine is prepared on Dec. 16 at Ascension SE Wisconsin Hospital in Franklin, Wisconsin.
SENTINEL VIA USA TODAY NETWORK] [MIKE DE SISTI / MILWAUKEE JOURNAL A COVID-19 vaccine is prepared on Dec. 16 at Ascension SE Wisconsin Hospital in Franklin, Wisconsin.
 ??  ??

Newspapers in English

Newspapers from United States